Drugs / Fluzone HD Quad
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04622592 | Nov 2020 → Apr 2022 | influenza | Medicago | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluzone HD Quad | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04622592 ↗ |
| Known as | Fluzone high dose (HD) Quadrivalent Influenza Vaccine | “Participants received one IM injection of 0.7 mL of 60 μg/strain of the Fluzone high dose (HD) Quadrivalent Influenza Vaccine on Day 0 into the deltoid region of the...” NCT04622592 ↗ |
| Modality | Vaccine | “Fluzone high dose (HD) Quadrivalent Influenza Vaccine” NCT04622592 ↗ |
| Route | Intramuscular | “one IM injection” NCT04622592 ↗ |